MUCOSAL MELANOMA
Clinical trials for MUCOSAL MELANOMA explained in plain language.
Never miss a new study
Get alerted when new MUCOSAL MELANOMA trials appear
Sign up with your email to follow new studies for MUCOSAL MELANOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Scientists test Triple-Threat attack on rare, aggressive skin cancer
Disease control Not yet recruitingThis study is testing a new combination treatment for advanced mucosal melanoma, a rare and aggressive cancer. It combines two drugs (carilizumab and apatinib) with targeted radiation therapy. The main goal is to see if this approach can keep the cancer from growing for at least …
Matched conditions: MUCOSAL MELANOMA
Phase: PHASE2 • Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
New hope for Tough-to-Treat skin cancers in clinical trial
Disease control Not yet recruitingThis study is testing a new combination of two immunotherapy drugs (iparomlimab and tuvoraleimab) with three standard chemotherapy drugs for people with advanced acral or mucosal melanoma. The goal is to see if this five-drug combination can better control the cancer and is safe …
Matched conditions: MUCOSAL MELANOMA
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated Mar 24, 2026 12:03 UTC